Economic burden and co-morbidities of atrial fibrillation in a privately insured population

By Wu Eric Q.   Birnbaum Howard G.   Mareva Milena   Tuttle Edward   Castor Adam R.   Jackman Warren   Ruskin Jeremy  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1693-1699

Informa Healthcare

Access to resources Recommend Favorite

Impact of co‐morbidities on resource use and adherence to guidelines among commercially insured adults with new visits for back pain

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 23, Iss. 6, 2017-12 ,pp. : 1218-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine

By Wu N   Chen S   Boulanger L   Rao P   Zhao Y  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1131-1139

Informa Healthcare

Access to resources Recommend Favorite

Assessing incidence and economic burden of genital warts with data from a US commercially insured population

By Hoy Tracey   Singhal Puneet K.   Willey Vincent J.   Insinga Ralph P.  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2343-2351

Informa Healthcare

Access to resources Recommend Favorite

Respiratory outcomes, utilization and costs 12 months following a respiratory syncytial virus diagnosis among commercially insured late-preterm infants

By Palmer Liisa   Hall Caroline B.   Katkin Julie P.   Shi Nianwen   Masaquel Anthony S.   McLaurin Kimmie K.   Mahadevia Parthiv J.  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 403-412

Informa Healthcare

Access to resources Recommend Favorite